ChatGPT Meets Drug Discovery: Unlocking New Frontiers

• A Boston-based clinical stage company is focused on developing innovative immunotherapies for cancer treatment.
• A major challenge faced was- managing diverse biomarker data generated by multiple CROs and assays. The data lacked consistency, proper formatting, and readiness for analysis, resulting in bottlenecks.
• The company adopted Polly by Elucidata to address their data harmonization and management challenges. Polly facilitated data aggregation, interactive dashboard creation, data cleaning, and linkage with clinical metadata. This resulted in substantial improvements:
  -Approximately 25x faster analysis time.
  -Accelerated dashboard development.
  -Enhanced cross-cohort comparisons.

‍